Ocella is the generic form of Yasmin birth control, produced by Bayer Pharmaceuticals.  Yasmin and Ocella were approved by the FDA as oral contrceptives and to treat symptoms of Premenstrual dysphoric disorder (PMDD).  Neither drug was approved to treat acne or PreMenstrual Syndrome (PMS).

Ocella has been marketed throughout the country in a misleading way, and women have suffered needlessly, claims the potential class action Ocella lawsuit.  Television commercials feature women apparently suffering from PMS symptoms such as bloating and breakouts, neither of which are symptoms of PMDD.  The ads show happy women with very clear skin, supposedly because they had taken Ocella, and this is misleading.

In addition to making misleading claims for the drug, the Ocella lawsuit states that dangerous side effects are downplayed or not even mentioned, giving a false impression of the drug.  Ocella side effects such as blood clots and gall bladder disease are not sufficiently addressed in the TV commercials.

Blood clots are serious health risks, and can lead to stroke, heart attack, and even death.  Gall bladder disease and gallstones may lead to gall bladder removal surgery.  Participants in the Ocella lawsuit seek compensation for their pain and suffering, as well as medical expenses.

By combining the hormones estrogen and progestin, Yaz treats PMDD and also stops 99 percent of pregnancies.  It’s prescribed as a cure-all that can solve several health care issues in one pill.  About 5% of women suffer from premenstrual dysphoric disorder (PMDD), which can be described as PMS times ten.  Women suffer not only physical symptoms but also sufffer from depession and anxiety.  Yaz birth control relieves much of this and has thus been very popular since its introduction in 2006.

But now we’re discovering something called Yaz Gallbladder disease.  It’s a serious side effect of taking Yaz, one not to be ignored since women are already twice as like to suffer from gallstones as men.  Yaz gallbladder disease occurs because the pills increase the cholesterol levels in the bile.  It also decreases gallbladder movement and this can lead to gallstones.  When a gallstone gets trapped in a bile duct, serious problems are encountered.

Yaz gallbladder disease may result in the patient needing laproscopic gallbladder surgery, which has its own set of adverse side effects that continue post-surgery.  If you have taken Yaz birth control, you may want to stay informed about upcoming birth control lawsuits and stay abreast of research developments  in the Yaz and Yasmin industry.  Yaz Gallbladder disease is a serious issue that requires your attention as soon as you think you may be feeling symptoms.

How does Yasmin work?  Drospirenone and ethinyl estradiol prevent ovulation and cause the cervical and uterine lining.  These changes make it harder for sperm to reach the eggs, and harder for fertilized eggs to attach to the uterus.

Yasmin birth control is used as a contraceptive, acne treatment, and as treatment for premenstrual dysphoric disorder (PMDD), commonly known as severe PMS.  It’s been on the market since 2001, and its sister drug called Yaz, was approved in 2006.

So what’s the problem with Yasmin and Yaz?  People claim they cause strokes, and they are suing Bayer Healthcare Pharmaceuticals.  Already more than 125 cases have come into their New Jersey Headquarters, with around six new cases every day.  The Yasmin birth control lawsuit also claims that heart attacks, deep vein thrombosis, gallbladder disease, pulmonary embolisms and death are also caused by the contraceptive, which is very widely used, especially by women under 35.

Already, Bayer Healthcare Pharmaceuticals were warned by the FDA over their tv commercials that claimed Yasmin’s ability to relieve PMS.  That had not been an FDA-approved use.  FDA has also cited Bayer for quality control issues in their labs.

Other contraceptives have been linked to increased risk for blood clots (Nuvaring by Schering-Plough and the Ortho Evra patch) but only Yasmin and Yaz have been linked to gallbladder problems.

A Federal case against Yaz has been prepared for pretrial proceedings in an MDL (multidistrict litigation) in East St. Louis.  The same is underway in New Jersey and Pennsylvania.  In New Jersey, you have until December 31 2009 to offer input.